Total Payments
$469,821
2024 Payments
$118,632
Companies
36
Transactions
464
Medicare Patients
2,516
Medicare Billing
$421,233
Payment Breakdown by Category
Other$415,190 (88.4%)
Travel$40,752 (8.7%)
Food & Beverage$11,045 (2.4%)
Consulting$2,756 (0.6%)
Education$77.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $415,190 | 140 | 88.4% |
| Travel and Lodging | $40,752 | 126 | 8.7% |
| Food and Beverage | $11,045 | 189 | 2.4% |
| Consulting Fee | $2,756 | 4 | 0.6% |
| Education | $77.27 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $252,758 | 204 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $104,259 | 87 | $0 (2024) |
| Merck Sharp & Dohme LLC | $100,960 | 102 | $0 (2024) |
| Janssen Biotech, Inc. | $10,702 | 15 | $0 (2024) |
| Galvanize Therapeutics, Inc | $116.19 | 1 | $0 (2023) |
| Incyte Corporation | $106.55 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $89.23 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $72.16 | 4 | $0 (2020) |
| Genentech USA, Inc. | $65.44 | 5 | $0 (2023) |
| PFIZER INC. | $62.53 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118,632 | 116 | Regeneron Healthcare Solutions, Inc. ($79,987) |
| 2023 | $68,370 | 72 | Merck Sharp & Dohme LLC ($27,844) |
| 2022 | $62,158 | 46 | Janssen Pharmaceuticals, Inc ($61,916) |
| 2021 | $30,164 | 34 | Janssen Pharmaceuticals, Inc ($29,918) |
| 2020 | $15,269 | 17 | Merck Sharp & Dohme Corporation ($7,927) |
| 2019 | $44,137 | 42 | Janssen Pharmaceuticals, Inc ($24,418) |
| 2018 | $56,305 | 50 | Janssen Pharmaceuticals, Inc ($31,884) |
| 2017 | $74,786 | 87 | Janssen Pharmaceuticals, Inc ($60,413) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 2 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Travel and Lodging | Cash or cash equivalent | $375.20 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $184.61 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,190.00 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,392.00 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $473.31 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $507.24 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,392.00 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,392.00 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $411.38 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $296.14 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $62.98 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.16 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,660.00 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,190.00 | General |
| Category: Oncology | ||||||
| 09/14/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $85.42 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,124.00 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $110.03 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 602 | 979 | $266,032 | $82,331 |
| 2022 | 10 | 598 | 1,140 | $289,224 | $111,360 |
| 2021 | 10 | 672 | 1,325 | $327,933 | $130,449 |
| 2020 | 11 | 644 | 1,204 | $279,407 | $97,093 |
Total Patients
2,516
Total Services
4,648
Medicare Billing
$421,233
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 111 | 374 | $118,558 | $39,468 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 199 | $46,765 | $13,065 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 169 | $26,702 | $7,484 | 28.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $21,792 | $5,992 | 27.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $12,252 | $3,563 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 47 | $7,567 | $2,862 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $11,913 | $2,767 | 23.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 24 | $5,568 | $2,199 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 15 | $4,680 | $1,681 | 35.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,880 | $1,604 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 14 | $3,262 | $1,067 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 13 | $2,093 | $578.96 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 351 | $111,267 | $38,644 | 34.7% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 47 | 172 | $27,520 | $27,376 | 99.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 221 | $51,935 | $14,970 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 54 | 54 | $24,516 | $7,053 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 152 | $24,016 | $6,917 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 78 | $12,558 | $4,330 | 34.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 34 | $10,370 | $3,627 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $11,552 | $3,392 | 29.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $9,922 | $3,314 | 33.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 24 | $5,568 | $1,737 | 31.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 85 | 338 | $107,146 | $39,035 | 36.4% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 50 | 206 | $32,960 | $33,471 | 101.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 326 | $76,610 | $22,876 | 29.9% |
About Dr. Mark Andolina, MD
Dr. Mark Andolina, MD is a Internal Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346451051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Andolina, MD has received a total of $469,821 in payments from pharmaceutical and medical device companies, with $118,632 received in 2024. These payments were reported across 464 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($415,190).
As a Medicare-enrolled provider, Andolina has provided services to 2,516 Medicare beneficiaries, totaling 4,648 services with total Medicare billing of $421,233. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Cincinnati, OH
- Active Since 05/24/2007
- Last Updated 10/28/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346451051
Products in Payments
- XARELTO (Drug) $252,758
- LIBTAYO (Biological) $104,259
- KEYTRUDA (Biological) $96,667
- RYBREVANT (Drug) $10,685
- ALIYA SYSTEM (Device) $116.19
- MONJUVI (Drug) $106.55
- IMBRUVICA (Drug) $53.95
- XTANDI (Drug) $46.06
- Xtandi (Drug) $40.10
- PADCEV (Biological) $36.14
- NERLYNX (Drug) $26.27
- Phesgo (Biological) $24.94
- SAMSCA (Drug) $24.50
- ENHERTU (Biological) $24.33
- Lenvima (Drug) $24.27
- KISQALI (Drug) $22.68
- BENDEKA (Drug) $22.64
- CALQUENCE (Drug) $21.24
- Fabhalta (Drug) $20.16
- KIMMTRAK (Drug) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cincinnati
Jonathan Bernstein, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Nelson Watts, M.d, M.D
Internal Medicine — Payments: $788,194
Internal Medicine $788,194
Robert Baughman, M.d, M.D
Internal Medicine — Payments: $766,919
Internal Medicine $766,919
Amit Govil, M.d, M.D
Internal Medicine — Payments: $410,360
Internal Medicine $410,360
Vincent Martin, Md, MD
Internal Medicine — Payments: $332,673
Internal Medicine $332,673
Jean Elwing, Md, MD
Internal Medicine — Payments: $266,596
Internal Medicine $266,596